<DOC>
	<DOCNO>NCT01562483</DOCNO>
	<brief_summary>Persistent postsurgical abdominal pain ( PPAP ) difficult treat pain . This pain persist month even year significantly diminish quality life . The exact underlying cause pain persistence still unclear , make treatment still challenge . The promising analgesic effect Δ9-THC previous research , plus improved bioavailability Namisol® comparison previous Δ9-THC substance form basis present research proposal . The current study aim investigate analgesic efficacy Namisol® add-on analgesic long-term treatment ( 52 day ) persistent postsurgical abdominal pain .</brief_summary>
	<brief_title>The Analgesic Efficacy Δ9-THC ( Namisol® ) Patients With Persistent Postsurgical Abdominal Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Aged 18 year old Pain develop surgical procedure Pain duration exceed 3 month , average NRS≥3 Stable dos intake analgesic past 2 month The patient inform study , understood information sign informed consent form Diagnosed irritated bowel syndrome ( IBS ) chronic pancreatitis Patient take cannabinoids regular basis least one year Patient feel pinprick test low extremity Patient body mass index ( BMI ) 36,0 kg/m2 Patient suffers serious painful condition chronic pancreatitis Patient significant medical disorder may interfere study may pose risk patient Patient use kind concomitant medication may interfere study may pose risk patient Patient tolerate oral intake medication liquid , refrain oral intake medical reason Patient demonstrate clinical relevant deviation electrocardiogram ( ECG ) Patient actual moderate severe renal impairment Patient actual moderate severe hepatic impairment Patient presence history major psychiatric illness Patient experience epileptic seizure past Patient demonstrate clinically significant laboratory abnormality Patient demonstrate positive urine drug screen THC , cocaine , MDMA , amphetamines Patient demonstrate positive test result hepatitis B surface antigen , hepatitis C antibody HIV antibody test Patient history sensitivity / idiosyncrasy THC Patient know suspect lactose intolerance Female patient pregnant breastfeeding Patient intend conceive child course study Patient participate another investigational drug study Patient clinical significant exacerbation illness Patient unwilling unable comply lifestyle guideline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>postsurgical pain</keyword>
	<keyword>abdominal pain</keyword>
	<keyword>visceral pain</keyword>
	<keyword>chronic pain</keyword>
</DOC>